Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Abstract
Highly potent, but poorly water-soluble, drug candidates are common outcomes of contemporary drug discovery programmes and present a number of challenges to drug development - most notably, the issue of reduced systemic exposure after oral administration. However, it is increasingly apparent that formulations containing natural and/or synthetic lipids present a viable means for enhancing the oral bioavailability of some poorly water-soluble, highly lipophilic drugs. This Review details the mechanisms by which lipids and lipidic excipients affect the oral absorption of lipophilic drugs and provides a perspective on the possible future applications of lipid-based delivery systems. Particular emphasis has been placed on the capacity of lipids to enhance drug solubilization in the intestinal milieu, recruit intestinal lymphatic drug transport (and thereby reduce first-pass drug metabolism) and alter enterocyte-based drug transport and disposition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional absorption and bioavailability assessments, and the body-weight regressions built upon them, implicitly assume the portal route and seldom quantify the lymphatic contribution, even though, for suitable compounds, it can represent a substantial fraction of systemic exposure [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“This route becomes quantitatively relevant only for compounds that combine high lipophilicity with appreciable long-chain triglyceride solubility, for which a log P greater than 5 and a lipid solubility above approximately 50 mg/g are commonly cited as approximate thresholds [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“Because lymphatic delivery reaches the systemic circulation while bypassing hepatic first-pass metabolism, it can materially increase the oral bioavailability of affected compounds and lower their apparent first-pass loss in a manner that a body-weight regression of systemic clearance or volume cannot anticipate [28,29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“For highly lipophilic drugs, a fraction of the absorbed dose can bypass the portal circulation entirely and reach the systemic circulation via the intestinal lymphatics, associated with triglyceride-rich lipoproteins (chylomicrons) assembled within the enterocyte [28,29].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“The extent of transport is highly sensitive to prandial state and to the type and quantity of co-administered lipid, which differ across preclinical study designs and between the fasted conditions typical of first-in-human protocols and the fed conditions under which lymphatic transport is greatest [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“This is especially the case when potent, but highly lipophilic, drug candidates arise from complex chemical scaffolds and multiple high-throughput activity screen”
BackgroundNuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,648
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,577
Smit, J. J. M., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van Roon, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,456
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401 · cited 1×
“In addition to the potential effect of lipidic excipients (primarily surfactants) on P-gp-mediated efflux, Benet and co-workers have recently suggested that high-fat meals could inhibit P-g”
BackgroundSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J.-M. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,301
Cited by
Items 801–900 of 1,003
Fang, X. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28052 · Cited by 35
El-Enin, H. A. A. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.983113 · Cited by 35
Yao, M., Chen, J., Zheng, J., Song, M., McClements, D. J., & Xiao, H. (2013) · Food & Function · doi:10.1039/c3fo60335k · Cited by 35
Lin, S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.001 · Cited by 35
Cofrades, S., Bou, R., Flaiz, L., Garcimartín, A., Benedí, J., Mateos, R., Sánchez-Muniz, F. J., Olivero-David, R., & Jiménez-Colmenero, F. (2017) · Journal of Food Science and Technology · doi:10.1007/s13197-017-2604-x · Cited by 35
“Previous studies have suggested that the bioavailability of lipid components depends on their physicochemical properties as well as on the structural organization of the lipids in the matrix (Porter et al. 2007).”
BackgroundMa, Y., He, H., Fan, W., Li, Y., Zhang, W., Zhao, W., Qi, J., Lü, Y., Dong, X., & Wu, W. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00380 · Cited by 35
Libinaki, R., & Gavin, P. D. (2017) · Nutrients · doi:10.3390/nu9091042 · Cited by 35
Silica nanoparticles on the oral delivery of insulin
Tan, X., Liu, X., Zhang, Y., Zhang, H., Lin, X., Pu, C., Gou, J., He, H., Yin, T., Zhang, Y. X., et al. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1503250 · Cited by 35
Polymer microsphere for water-soluble drug delivery via carbon dot-stabilizing W/O emulsion
Wang, L., Gao, J., An, Z., Zhao, X., Yao, H., Zhang, M., Tian, Q., Zhai, X., & Liu, Y. (2018) · Journal of Materials Science · doi:10.1007/s10853-018-03197-7 · Cited by 35
Yasmin, R., Tan, A., Bremmell, K. E., & Prestidge, C. A. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23914 · Cited by 34
Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.01.010 · Cited by 34
Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery
Jeong, S., Jang, J.-H., Cho, H., & Lee, Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1060-0 · Cited by 34
Opportunities and challenges in developing orally administered cannabis edibles
Chen, P. X., & Rogers, M. A. (2019) · Current Opinion in Food Science · doi:10.1016/j.cofs.2019.02.005 · Cited by 34
Nanoencapsulation of functional food ingredients
Zhu, J., & Huang, Q. (2019) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2019.03.005 · Cited by 34
A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations
Barber, B. W., Dumont, C., Caisse, P., Simon, G. P., & Boyd, B. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122107 · Cited by 34
“The oral bioavailability of lipophilic drugs can be improved with the coadministration of lipids in the form of food- or lipid-based formulations [23,24].”
BackgroundTuning the membrane fluidity of liposomes for desirable in vivo fate with enhanced drug delivery
Zhao, J., & Mao, S. (2021) · Advances in biomembranes and lipid self-assembly · doi:10.1016/bs.abl.2021.11.003 · Cited by 34
Opportunities for milk and milk-related systems as ‘new’ low-cost excipient drug delivery materials
Salim, M., Eason, T., & Boyd, B. J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114139 · Cited by 34
Self-assembling bubble carriers for oral protein delivery
Chuang, E., Lin, K., Lin, P.-Y., Chen, H., Wey, S., Mi, F., Hsiao, H., Chen, C.-T., & Sung, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.035 · Cited by 34
“the intestinal milieu is a prerequisite for their absorption [32].”
BackgroundJannin, V., Rodier, J.-D., & Musakhanian, J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.007 · Cited by 34
“Polyoxylglycerides on the other hand are utilized as solubility and bioavailability enhancers in self emulsifying systems (Chambin et al., 2009; Fernandez et al., 2009; Porter et al., 2007; Williams et al., 2013).”
BackgroundInorganic matrices: an answer to low drug solubility problem
Perioli, L., & Pagano, C. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.733693 · Cited by 34
“The increase of drug dissolution depends on the presence of exogenous lipids in the duodenum suitable to stimulate the secretion of biliary lipids able to combine to lipid digestion products to generate a series of colloidal species including micelles, mixed micelles, vesicles and emulsion droplets [37].”
BackgroundBremmell, K. E., Tan, A., Martin, A. L., & Prestidge, C. A. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23406 · Cited by 34
Rapid determination of drug solubilization versus supersaturation in natural and digested lipids
Gautschi, N., Bergström, C. A. S., & Kuentz, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.015 · Cited by 34
Heider, M., Hause, G., & Mäder, K. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.007 · Cited by 34
Suys, E. J. A., Warren, D. B., Pham, A. C., Nowell, C. J., Clulow, A. J., Benameur, H., Porter, C. J. H., Pouton, C. W., & Chalmers, D. K. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.11.028 · Cited by 34
Self-citationCui, W., Zhang, S., Zhao, H., Luo, C., Sun, B., Li, Z., Sun, M., Ye, Q., Sun, J., & He, Z. (2018) · Biomaterials Science · doi:10.1039/c8bm00947c · Cited by 34
Food structure engineering for nutrition, health and wellness
Kaufmann, S. F. M., & Palzer, S. (2011) · Procedia Food Science · doi:10.1016/j.profoo.2011.09.219 · Cited by 34
“, “oral administration” in pharmaceutical terms), this dictates, that the active substance must first dissolve within the gastrointestinal tract before partitioning into and then across the enterocyte [12].”
BackgroundCo-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy
Cui, W., Zhao, H., Wang, C., Chen, Y., Luo, C., Zhang, S., Sun, B., & He, Z. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1616237 · Cited by 33
“These results showed that SNEDDS can increase the intestinal absorption of DTX to some extent, probably due to increasing dissolution rate of drugs, membrane permeability and inhibiting the P-gp mediated efflux (Porter et al., 2007; Singh et al., 2013).”
BackgroundDesign and Optimization of Febuxostat-loaded Nano Lipid Carriers Using Full Factorial Design
Bhatt, S., Kamboj, R., SHARMA, J. B., Kumar, M., Saini, V., & ., S. M. (2019) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2019.32656 · Cited by 33
Kazi, M., Nasr, F. A., Noman, O. M., Alharbi, A., Alqahtani, M. S., & Alanazi, F. K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111107 · Cited by 33
“The observation data indicated that formulations F2–F6 have a good self-nanoemulsification ability and completely dispersed in less than a minute when diluted with water, with a little help from low agitation of peristaltic activity [31].”
BackgroundRecent Advances in Oral Peptide or Protein-Based Drug Liposomes
Cui, J. G., Wen, Z., Zhang, W., & Wu, W. (2022) · Pharmaceuticals · doi:10.3390/ph15091072 · Cited by 33
“The type of lipid, length and saturation of lipid chains, and the logP value of the loaded drug are potentially useful for forming chylomicrons [54].”
BackgroundLiu, X., Lin, Y., Yao, K., Xie, J., Xiao, J., & Cao, Y. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134194 · Cited by 33
Recent Advances in Cancer Immunotherapy Delivery Modalities
Muthukutty, P., Woo, H. Y., Murali, R., & Yoo, S. Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020504 · Cited by 33
Kumar, R., Kumar, S., & Sinha, V. R. (2015) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2015.1038351 · Cited by 33
Zhou, H., Wan, J., Wu, L., Yi, T., Liu, W., Xu, H., & Yang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084530 · Cited by 33
“It is also suggested that the formation of micelles from SEDDS may enhance the mass transport of molecules across the unstirred water layer in GI tract [39].”
BackgroundIbrahim, F., Gershkovich, P., Sivak, O., Wasan, E. K., & Wasan, K. M. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.02.008 · Cited by 34
Salman, S., Page‐Sharp, M., Batty, K. T., Kose, K., Griffin, S., Siba, P. M., Ilett, K. F., Müeller, I., & Davis, T. M. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06232-11 · Cited by 33
“However, PQ base is less water soluble than PQ tetraphosphate, and exogenous lipids are known to increase the solubility of lipophilic drugs and thus affect the extent of absorption (35).”
BackgroundKorzhikov-Vlakh, V. A., Averianov, I. V., Litvinchuk, E., & Tennikova, T. B. (2016) · Journal of Microencapsulation · doi:10.3109/02652048.2016.1144818 · Cited by 33
“It is known that some hydrophobic drugs are very effective regarding their therapeutic action, but their application is impossible without specially designed delivery systems (Odeberg et al., 2003; Porter et al., 2007; Frelichowska et al., 2009; Kuentz, 2012).”
BackgroundSwarnakar, N. K., Thanki, K., & Jain, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400601g · Cited by 33
Biological Voyage of Solid Lipid nanoparticles: A Proficient Carrier in Nanomedicine
Ali, H., & Singh, S. K. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0038 · Cited by 33
Li, Q., Xia, D., Tao, J., Shen, A., He, Y., Gan, Y., & Wang, C. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.029 · Cited by 33
Christiansen, A., Backensfeld, T., Kühn, S., & Weitschies, W. (2011) · Die Pharmazie · doi:10.31083/ph.2011.1033 · Cited by 33
Santiago, R. R., Silva, K. G. D. H. E., dos Santos, N. D., Genre, J., Lione, V. D. O. F., Silva, A. L., Marcelino, H. R., Gondim, A. D., & do Egito, E. S. T. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.10.003 · Cited by 32
Advanced delivery strategies facilitating oral absorption of heparins
Fang, G., & Tang, B. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.11.006 · Cited by 32
Controlled Transdermal Release of Antioxidant Ferulate by a Porous Sc(III) MOF
Osorio-Toribio, G., Velásquez-Hernández, M. D. J., Mileo, P. G. M., Zárate, J. A., Águila-Rosas, J., Leyva‐Gómez, G., Sánchez‐Sánchez, R., Magaña, J. J., Pérez-Díaz, M. A., Lázaro, I. A., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101156 · Cited by 32
Drug-delivery nanocarriers for skin wound-healing applications
Medina-Cruz, D., Saleh, B., Vernet-Crua, A., Ajó, A., Roy, A. K., & Webster, T. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816413-6.00022-8 · Cited by 32
Lipidic nanomaterials to deliver natural compounds against cancer: a review
Chaudhari, V. S., Murty, U. S., & Banerjee, S. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01042-5 · Cited by 32
Kundu, S., Malik, S., Ghosh, M., Nandi, S., Pyne, A., Debnath, A., & Sarkar, N. (2021) · Langmuir · doi:10.1021/acs.langmuir.0c03037 · Cited by 32
Joseph, A., Balakrishnan, A., Shanmughan, P., Maliakel, B. P., & Krishnakumar, I. M. (2022) · ACS Omega · doi:10.1021/acsomega.2c00116 · Cited by 32
Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies
Mesut, B., Al-Mohaya, M., Gholap, A. D., Yeşilkaya, E., Das, U., Akhtar, M. S., Sah, R., Khan, S., Moin, A., & Faiyazuddin, M. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03212-6 · Cited by 32
“In recent decades, nanomedicines for oral chemotherapy have become increasingly popular (Bakhru et al. 2013; Porter et al. 2007).”
Aburahma, M. H. (2014) · Drug Delivery · doi:10.3109/10717544.2014.956240 · Cited by 32
“The amounts of lipid formulation studied are often comparatively high for this species and physiologically the rat is known for continuous bile secretions (Porter et al., 2007; Kuentz, 2012).”
BackgroundInfluentialIchihashi, T., Satoh, T., Sugimoto, C., & Kajino, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060068 · Cited by 32
“For many years, lipid-based carriers have been investigated for potential applications in drug, DNA, peptide, and protein delivery [25,26].”
BackgroundThe influence of lung surfactant liquid crystalline nanostructures on respiratory drug delivery
Das, S. C., & Stewart, P. J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.029 · Cited by 32
Truzzi, E., Bongio, C., Sacchetti, F., Maretti, E., Montanari, M., Iannuccelli, V., Vismara, E., & Leo, E. (2017) · Molecules · doi:10.3390/molecules22060963 · Cited by 32
“It is known that lipid nanoparticles based on triglycerides with a high carbon chain length are less susceptible to intestinal lipase than those composed of a shorter carbon chain and are preferably transported into the intestinal lymphatic system [11,25,28].”
BackgroundXu, F., Pandya, J. K., Chung, C., McClements, D. J., & Kinchla, A. J. (2017) · Food Research International · doi:10.1016/j.foodres.2017.11.033 · Cited by 32
Lee, Y.-C., Dalton, C. R., Regler, B. P., & Harris, D. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1483395 · Cited by 32
“It is known that the FAs arising from lipid digestion interact with bile acids and phospholipids to form mixed micelles to solubilize the drug prior to absorption in the small intestine [6].”
BackgroundImproving the Oral Absorption of Poorly Soluble Drugs Using SEDDS and S-SEDDS Formulations
Morozowich, W., & Gao, P. (2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53242-8.00019-9 · Cited by 32
Heade, J., Maher, S., Bleiel, S. B., & Brayden, D. J. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.02.012 · Cited by 31
Biomaterials that regulate fat digestion for the treatment of obesity
Joyce, P. M., Meola, T. R., Schultz, H. B., & Prestidge, C. A. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.04.011 · Cited by 31
Rehman, S., Nabi, B., Baboota, S., & Ali, J. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105005 · Cited by 31
Ge, R., Zhu, H., Zhong, J. Q., Wang, H., & Tao, N. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.997706 · Cited by 31
Ahmad, N., Khalid, M. S., Khan, M. F., & Ullah, Z. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104094 · Cited by 31
Jia, J. X., & Wasan, K. M. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j33s3z · Cited by 31
“bioavailability of many hydrophobic oral drugs (4).”
Li, X., Liu, S., Wang, Q., & Lu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87471 · Cited by 31
“29 It was reported that PEG materials having a molecular weight over 2,000 are difficult to absorb by the epithelial membrane through paracellular transport or macropinocytosis.”
Li, Y., & McClements, D. J. (2013) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2013.04.016 · Cited by 31
Lee, K. W. Y., Porter, C. J. H., & Boyd, B. J. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-9976-7 · Cited by 31
“6 × 150 mm Phenomenex Luna C8 (2) (5 μm, 100 Å) analytical column and 15×3 mm Brownlee RP-18 (7 μm) guard column.”
Self-citationXing, Z.-H., Wei, J., Cheang, T., Wang, Z., Zhou, X. Y., Wang, S., Chen, W., Wang, S., Luo, J., & Xu, A. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21625j · Cited by 31
EMULSOMES: AN EMERGING VESICULAR DRUG DELIVERY SYSTEM
Kumar, R., Seth, N., & Kumar, S. (2013) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v3i6.665 · Cited by 31
“[17] Lipid-based excipients can influence oral absorption via various physiological effects such as retarded gastric emptying,[18] stimulating bile flow, and secretion of pancreatic juice increasing the membrane lipid fluidity or acting directly onto enterocytes-based drug transport and disposition.[19-21] Figure 1: S…”
BackgroundAgbo, C. P., Umeyor, C. E., Kenechukwu, F. C., Ogbonna, J. D., Chime, S. A., Charles, L., Agubata, C. O., Ofokansi, K. C., & Attama, A. A. (2016) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2016.1171331 · Cited by 31
da Silva, G. S., Jange, C. G., Rocha, J. S. D. S., Chaves, M. A., & Pinho, S. C. (2016) · International Journal of Food Science & Technology · doi:10.1111/ijfs.13334 · Cited by 31
“The use of lipid formulations is an approach to increasing bioaccessibility (Parada & Aguilera, 2007) that has already been used for some time in the pharmaceutical field and is called lipid-based drug delivery (Porter et al., 2007).”
Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix
Guo, Y., Zhong, T., Duan, X.-C., Zhang, S., Yao, X. S., Yin, Y.-F., Huang, D., Ren, W., Zhang, Q., & Zhang, X. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1245371 · Cited by 31
“It has been reported that lipids can enhance drug solubilization in the intestinal milieu, interact with enterocyte-based transport or alter the pathway of drug transport to the systemic circulation to enhance the poorly water-soluble drug absorption and bioavailability (Porter et al., 2007).”
BackgroundStructure, physicochemical properties and pharmacokinetics of resveratrol and piperine cocrystals
He, H., Zhang, Q., Wang, J., & Mei, X. (2017) · CrystEngComm · doi:10.1039/c7ce01468f · Cited by 31
In vitro lipolysis of dairy and soy based infant formula
Thảo, N. T. P., Bhandari, B., Cichero, J. A. Y., & Prakash, S. (2018) · Food Research International · doi:10.1016/j.foodres.2018.01.003 · Cited by 31
Salim, M., Khan, J., Ramirez, G., Clulow, A. J., Hawley, A. M., Ramachandruni, H., & Boyd, B. J. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00541 · Cited by 31
Shah, M. K., Khatri, P., Vora, N., Patel, N., Jain, S. S. B. C., & Lin, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816506-5.00003-6 · Cited by 31
Feeney, O. M., Gracia, G., Brundel, D. H. S., Trevaskis, N. L., Cao, E., Kaminskas, L. M., & Porter, C. J. H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.002 · Cited by 31
Self-citationPlaza-Oliver, M., Fernández-Sainz, J., Robledo, V. R., Castro‐Vázquez, L., González-Fuentes, J., Marcos, P., Lozano, M. V., Santander-Ortega, M. J., & Jiménez, M. D. M. A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.031 · Cited by 31
Wang, M., Li, N., Guo, X., Chen, Y., Zhang, M., Sun, J., Farag, M. A., Simal‐Gándara, J., Sun, S., & Liu, C. (2025) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2025.111059 · Cited by 31
Lipid self-assembled structures for reactivity control in food
Sagalowicz, L., Moccand, C., Davídek, T., Ghanbari, R., Martiel, I., Negrini, R., Mezzenga, R., Leser, M. E., Blank, I., & Michel, M. (2016) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2015.0136 · Cited by 30
Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.063 · Cited by 30
Formation of Self-Assembled Mesophases During Lipid Digestion
Pham, A. C., Clulow, A. J., & Boyd, B. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.657886 · Cited by 30
Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases
Jogdeo, C. M., Panja, S., Kanvinde, S., Kapoor, E., Siddhanta, K., & Oupický, D. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202400 · Cited by 30
Andretto, V., Taurino, G., Guerriero, G., Guérin, H., Laine, E., Bianchi, M. G., Agusti, G., Briançon, S., Bussolati, O., Montembault, A., et al. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00260 · Cited by 30
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Chen, C., Beloqui, A., & Xu, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115117 · Cited by 30
Zhang, X., Wang, H., Zhang, T., Zhou, X., & Wu, B. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.06.008 · Cited by 30
“Once inside the enterocytes, the hydrophobic components can be assembled into chylomicrons with endogenous phospholipid, cholesterol and apolipoproteins in the smooth endoplasmic reticulum (Porter et al., 2007).”
BackgroundSilica-lipid hybrid microcapsules: Influence of lipid and emulsifier type on in vitro performance
Lim, L. H., Tan, A., Simović, S., & Prestidge, C. A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.038 · Cited by 30
Zhang, Z., Cao, H., Jiang, S., Liu, Z., He, X., Yu, H., & Li, Y. (2014) · Small · doi:10.1002/smll.201400799 · Cited by 30
Stability and physicochemical characterization of novel milk-based oral formulations
Kytariolos, J., Charkoftaki, G., Smith, J. R., Voyiatzis, G. A., Chrissanthopoulos, A., Yannopoulos, S. N., Fatouros, D. G., & Macheras, P. E. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.022 · Cited by 30
“This drug formulation leads to improved bioavailability of poorly watersoluble drugs (Humberstone and Charman, 1997; Mohsin et al., 2009; Porter et al., 2007; Pouton, 2000).”
BackgroundGuan, P., Lü, Y., Qi, J., & Wu, W. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.006 · Cited by 30
A Review On Self-Emulsified Drug Delivery System
Thakare, P., Mogal, V., Dusane, J. N., & Kshirsagar, S. J. (2016) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.51056 · Cited by 30
Groo, A., Pascale, M. D., Voisin‐Chiret, A. S., Corvaisier, S., Since, M., & Malzert‐Fréon, A. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.11.025 · Cited by 30
“To better mimic in vivo conditions (Porter et al., 2007), Jantratid et al.”
MethodLv, X., Zhang, S., Ma, H., Dong, P., Ma, X., Xu, M. Q., Tian, Y., Tang, Z., Peng, J., Chen, H., et al. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.05.008 · Cited by 30
Bioavailability Enhancement of Poorly Soluble Drugs: The Holy Grail in Pharma Industry
Rashid, M., Malik, M. Y., Singh, S. K., Chaturvedi, S., Gayen, J. R., & Wahajuddin, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130110653 · Cited by 30
Suram, D., Narala, A., & Veerabrahma, K. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1742142 · Cited by 30
“This observation resulted in the development of various lipid based delivery systems to improve the drug solubility and permeation across the gastro intestinal barrier [11].”
BackgroundAPI ionic liquids: probing the effect of counterion structure on physical form and lipid solubility
Ford, L., Tay, E., Nguyen, T., Williams, H. D., Benameur, H., Scammells, P. J., & Porter, C. J. H. (2020) · RSC Advances · doi:10.1039/d0ra00386g · Cited by 30
Self-citationChamieh, J., Merdassi, H., Rossi, J., Jannin, V., Demarne, F., & Cottet, H. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.032 · Cited by 30
“To enhance the bioavailability of these drugs, lipid based excipients were found to be a suitable strategy (Hauss, 2007; Porter et al., 2008; Porter et al., 2007).”
BackgroundCucurbituril-Oriented Nanoplatforms in Biomedical Applications
Cheng, G., Luo, J., Liu, Y., Chen, X., Wu, Z., & Chen, T. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01061 · Cited by 29
Tan, K. X., Ng, E. L. L., & Loo, S. C. J. (2021) · Materials · doi:10.3390/ma14112783 · Cited by 29
Study and Computational Modeling of Fatty Acid Effects on Drug Solubility in Lipid-Based Systems
Wyttenbach, N., Niederquell, A., Ectors, P., & Kuentz, M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.11.023 · Cited by 29
Zhan, X. L., Wu, Z., Chen, Z., & Cui, X. (2022) · Molecules · doi:10.3390/molecules27155032 · Cited by 29
“Until now, a variety of delivery systems have been developed, including solid dispersions [3], micelles [4], lipids [5], supramolecular assemblies [6], polymeric micelles [7,8], polyelectrolyte multilayer systems [9] and nano pharmaceutics [10,11].”
BackgroundPositive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies
Gallagher, C. I., Ha, D. A., Harvey, R. J., & Vandenberg, R. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000583 · Cited by 30
Metadata
- Authors
- Porter, C. J. H., Trevaskis, N. L., & Charman, W. N.
- Affiliations
- Monash University (AU)
- Corresponding author
- Porter, Christopher J. H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-03
- Volume
- 6
- Issue
- 3
- Pages
- 231-248
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2069235788
- Cited by
- 1,824
- References
- 253
- Citations by year
- 2026: 88 · 2025: 87 · 2024: 67 · 2023: 89 · 2022: 119 · 2021: 108 · 2020: 140 · 2019: 101 · 2018: 117 · 2017: 121 · 2016: 125 · 2015: 119 · 2014: 120 · 2013: 128 · 2012: 94
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- lipid-based drug delivery, oral bioavailability, lipophilic drugs, poorly water-soluble drugs, lipid excipients, first-pass metabolism, lipid-based formulations
- MeSH terms
- Administration, Oral, Animals, Pharmaceutical Preparations, Excipients, Humans, Intestinal Absorption, Lipids, Drug Design, Drug Delivery Systems, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.